Medical Oncologist
CION Cancer Clinics
TACE or TARE: how the two liver treatments differ | CION Cancer Clinics
TACE sends a chemotherapy drug into a liver tumour and then blocks its artery. TARE sends tiny radioactive beads into the same artery and treats the tumour mainly with radiation. Both are done through a small puncture, not an open operation. The choice depends on the tumour, whether it has reached the portal vein, how well the liver works and what the centre offers. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is the real difference between TACE and TARE?
- How do TACE and TARE compare on the practical points?
- What might lead a team towards one or the other?
- How is the choice between them usually made?
- What do families often get wrong about TACE and TARE?
- What should you ask before agreeing to either?
- Who is neither suitable for, and what can this page not tell you?
- Common questions about TACE and TARE
The short answer
What is the real difference between TACE and TARE?
TACE puts a chemotherapy drug into a liver tumour and then blocks its artery. TARE puts tiny radioactive beads into the same artery, so the tumour is treated mainly by radiation rather than by starving it of blood.
What they have in common
Both are done by an interventional radiologist, a doctor who treats disease by guiding thin tubes with scans. Both reach the liver through a small puncture in the leg or wrist. Both treat tumours inside the liver rather than the whole body, and neither is an open operation.
Where they part ways
TACE relies on cutting off the blood supply, so it causes more of the short illness called post-embolisation syndrome: pain, fever and feeling sick for a few days. TARE blocks vessels far less. That makes it possible in some people whose tumour has grown into the portal vein, where blocking the artery as well could harm the liver.
Why families ask this question
Often one centre suggests TACE and another mentions TARE. That does not mean one team is wrong. Both can be reasonable for the same person, and the choice often comes down to the tumour, the liver and what the centre can offer.
Side by side
How do TACE and TARE compare on the practical points?
TACE
TARE (Y-90)
Chemotherapy drug plus blocking particles
Radioactive beads, with far less blocking
Usually a single procedure day each time
A mapping visit first, then the treatment day
Pain, fever and sickness afterwards are common
Tiredness is common; fever and pain are usually milder
Often repeated in cycles over months
Often fewer sessions in total
Widely available across Telangana
Offered at fewer centres and usually costs more
What the team weighs
What might lead a team towards one or the other?
These are the factors doctors discuss. None of them decides your case on its own.
Tumour in the portal vein
When cancer has grown into this main liver vein, TARE is more often discussed, because heavy blocking with TACE could starve healthy liver too.
Size and number of tumours
A few moderate tumours are a common reason for TACE. A single large tumour, or one confined to one part of the liver, may lead the team to consider TARE.
How well the liver works
Both need reasonable liver function. When it is borderline, the team may treat a smaller area, choose a gentler approach, or advise against either.
Checked on bloods
- Bilirubin
- Albumin
- Clotting tests
Plans for surgery or transplant
Either may be used to hold a tumour in check while waiting. The team will choose the one that keeps the later operation safest.
What the centre can do
TARE needs special planning and radiation safety set-up. Ask whether the centre offers both, and if not, whether TARE was considered elsewhere.
Not sure whether this applies to you?
Ask an oncologistThe pathway
How is the choice between them usually made?
-
Scans of the liver
A contrast CT or MRI shows how many tumours there are, their size, and whether any have reached the portal vein.
-
Blood tests for liver function
These show how much healthy liver is working and how much treatment it can take.
-
A tumour board discussion
Surgeons, liver doctors, oncologists and interventional radiologists look at the scans together and agree what to offer.
-
The plan is explained to you
You should hear why one option was chosen, what the alternative was, and what happens if it does not work. Bring the family member who helps you decide.
-
A planning visit, for TARE only
A mapping procedure checks the arteries and how many beads would reach the lungs. Sometimes this changes the plan back to TACE.
Commonly believed
What do families often get wrong about TACE and TARE?
"TARE is newer, so it must be the stronger treatment."
Studies comparing them have not shown one clearly ahead for everyone. Each fits different situations, and newer does not mean better for your tumour.
"If TACE stops working, nothing else is left."
When TACE stops controlling the tumour, teams often discuss TARE, medicines that work through the whole body, or other options. Ask what the next step would be before you start.
"Choosing one means you can never have the other."
Some people have both at different times. What is possible later depends on how the liver copes with the first treatment.
"The centre suggesting TACE is just avoiding the costlier option."
TACE is often the standard first choice for tumours confined to the liver. It is fair to ask why TARE was not suggested, and a good team will explain.
Take this with you
What should you ask before agreeing to either?
- Why is this option being suggested for my tumour?
- Was the other option considered, and why not?
- How well is my liver working right now?
- How many sessions do you expect, and how is progress checked?
- What side effects should we watch for at home?
- Does my scheme or insurance cover this at your centre?
Being straight with you
Who is neither suitable for, and what can this page not tell you?
Neither TACE nor TARE is usually offered when the liver is failing, when there is a lot of fluid in the tummy, or when the cancer has spread widely outside the liver. In those situations, treating only the liver is unlikely to help and may make you feel worse.
When surgery or ablation may come first
A small tumour that can be removed, or destroyed with a needle, is often better treated that way. TACE and TARE are mainly for tumours that cannot be treated by those methods.
What this page cannot tell you
It cannot tell you which option is right for you, how well either will work, or how long its effect will last. Those answers depend on your scans, your blood results and your general strength, and they come from your treating team.
Questions we are asked
Common questions about TACE and TARE
Which one has more side effects?
TACE more often causes a few days of pain, fever and feeling sick, because the tumour's blood supply is cut off. TARE more often causes tiredness that can last a week or two. Both can rarely affect the liver, the gallbladder or the stomach. Your team will tell you what to watch for.
Which one needs a longer hospital stay?
Both are usually short. After TACE, many people stay a night or two while pain and fever settle. After TARE, many go home the same day or the next morning. The TARE mapping visit is also usually a short day-care stay.
Can TARE be used after TACE has stopped working?
Sometimes. If the liver is still working well and the cancer is still mainly in the liver, the team may discuss TARE, a whole-body medicine or another approach. Much depends on how the liver has coped with the TACE sessions so far.
Is one better if a transplant is planned?
Both have been used to keep a tumour in check while waiting for a transplant. The transplant team decides which fits their plan, since they need the liver and surrounding vessels in good condition for the operation.
Are the radioactive beads dangerous to my family?
The radiation stays mostly inside the liver and fades with time. You will get written advice about close contact with small children and pregnant family members for a short time. There is no radiation involved with TACE.
Why is TARE not offered at every centre?
It needs radioactive beads shipped for a set date, a physicist to plan the dose and radiation safety arrangements. Many centres offer TACE only. If TARE has been mentioned, ask where it is done and whether your scans can be reviewed by that team.
Can I get a second opinion on which one to choose?
Yes, and many families do. Bring every scan on a disc, the reports and recent blood tests. A second team can review the same images and tell you whether they would suggest the same approach, and why.
Does Aarogyasri or insurance cover both?
Coverage differs by scheme and policy, and TARE is not covered in the same way everywhere. Aarogyasri, CGHS, ECHS, EHS and cashless insurers each set their own rules. Call the helpline with your details and ask for both options to be checked against your cover.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Embolization therapy for liver cancer
- NICE — Selective internal radiation therapies for treating hepatocellular carcinoma (TA688)
- National Cancer Institute — Liver cancer treatment (PDQ), patient version
- Cancer.Net — Liver cancer: types of treatment
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Offered TACE or TARE and not sure why?
Tell us what the scans have shown so far and we will help you reach the right specialist to talk it through. One helpline serves every CION centre.